Abstract
Aging is generally interpreted according to two opposing paradigms: 1) as a non-adaptive phenomenon, caused by the age-related failure of homeostatic mechanisms; 2) as a specific function, favored by natural selection, which determines the self-destruction of the organism, namely explaining aging as phenoptosis. This interpretation requires genetically determined and regulated age-specific mechanisms, now well documented by an impressive and growing scientific evidence. It follows that, in principle, aging is modifiable even up to the condition, already existing for many species, of "negligible senescence", alias unlimited longevity.
Keywords: Aging, apoptosis, evolutionary gerontology, phenoptosis, cell turnover, telomere.
Current Aging Science
Title:The Concept of Phenoptosis and its Usefulness for Controlling Aging
Volume: 7 Issue: 1
Author(s): Giacinto Libertini
Affiliation:
Keywords: Aging, apoptosis, evolutionary gerontology, phenoptosis, cell turnover, telomere.
Abstract: Aging is generally interpreted according to two opposing paradigms: 1) as a non-adaptive phenomenon, caused by the age-related failure of homeostatic mechanisms; 2) as a specific function, favored by natural selection, which determines the self-destruction of the organism, namely explaining aging as phenoptosis. This interpretation requires genetically determined and regulated age-specific mechanisms, now well documented by an impressive and growing scientific evidence. It follows that, in principle, aging is modifiable even up to the condition, already existing for many species, of "negligible senescence", alias unlimited longevity.
Export Options
About this article
Cite this article as:
Libertini Giacinto, The Concept of Phenoptosis and its Usefulness for Controlling Aging, Current Aging Science 2014; 7 (1) . https://dx.doi.org/10.2174/1874609807666140521103706
DOI https://dx.doi.org/10.2174/1874609807666140521103706 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Marine n-3 Fatty Acids for Cardiovascular Risk Reduction and Disease Control in Rheumatoid Arthritis: “Kill Two Birds with One Stone”?
Current Pharmaceutical Design Inhibition of Sumoylation Alleviates Oxidative Stress-induced Retinal Pigment Epithelial Cell Senescence and Represses Proinflammatory Gene Expression
Current Molecular Medicine Subject Index To Volume 4
Cardiovascular & Hematological Agents in Medicinal Chemistry Stroke Suggests Increased Risk of Dementia
Current Alzheimer Research Therapeutic Strategies Targeting Endothelial Function in Humans:Clinical Implications
Current Vascular Pharmacology New Insight in Antiplatelet Therapy Monitoring in Cardiovascular Patients: From Aspirin to Thienopyridine
Cardiovascular & Hematological Disorders-Drug Targets Left Ventricular Hypertrophy in Isolated Aortic Stenosis: Primetime for the Ventricle
Current Pharmaceutical Biotechnology Sirtuin Modulators: Mechanisms and Potential Clinical Implications
Current Medicinal Chemistry Novel Options for the Pharmacological Treatment of Chronic Anal Fissure – Role of Botulin Toxin
Current Clinical Pharmacology Should the Incorporation of Structural Alerts be Restricted in Drug Design? An Analysis of Structure-Toxicity Trends with Aniline-Based Drugs
Current Medicinal Chemistry Advanced Glycation and ROS: A Link between Diabetes and Heart Failure
Current Vascular Pharmacology Oxidative Stress, Antioxidants, and Endothelial Function
Current Medicinal Chemistry Pharmacotherapy of Mixed Dyslipidemia in the Metabolic Syndrome
Current Clinical Pharmacology Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Anacetrapib: A New Weapon Against Dyslipidemia
Current Clinical Pharmacology Risk Factors for Lung Cancer in Never Smokers: A Recent Review Including Genetics
Current Respiratory Medicine Reviews Hypertensive Pharmacogenomics in African Americans
Current Pharmacogenomics Neuropeptide Mimetics and Antagonists in the Treatment of Inflammatory Disease: Focus on VIP and PACAP
Current Topics in Medicinal Chemistry A Review of the Hypoglycemic Effects of Five Commonly Used Herbal Food Supplements
Recent Patents on Food, Nutrition & Agriculture Subclinical Thyroid Dysfunction and Cardiovascular Outcomes among Prospective Cohort Studies
Endocrine, Metabolic & Immune Disorders - Drug Targets